Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

Recruiting

Phase 2

Prevention of COVID-19 Infection to Severe Pneumonia or ARDSPrevention of COVID-19 Infection to Severe Pneumonia or ARDS

Sponsor:

Enzychem Lifesciences Corporation

Code:

NCT04569227

Conditions

Covid19 Pneumonia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EC-18

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Enzychem Lifesciences Corporation on 2021-06-10.